The roller coaster ride to the first GLP-1 obesity drug While approved first as a drug for diabetes, very early on in its development, when Knudsen first began work on liraglutide she wondered if the same drug could also be used as a treatment of obesity (Molteni, Chen)
They are not FDA-approved for treating diabetes or obesity and are not substitutes for prescription medications or evidence-based lifestyle interventions for metabolic health
For patients researching GLP-1 medications like semaglutide and tirzepatide in 2026, Tmates has emerged as a high-volume provider Tmates Cost & Pricing 2026: How Much Does GLP-1 Treatment Really Cost
Cardiovascular disease
Food and Drug Administration (FDA), the approved dosages for some of the commonly prescribed GLP-1 agonists are as follows: Semaglutide (Ozempic): 0.5 mg, 1 mg, or 2 mg once weekly for type 2 diabetes, and up to 2.4 mg once weekly for chronic weight management (marketed as Wegovy)
Alternatives to Hers Hers is one of many weight loss platforms available to help you meet your goals